Avastin and Lucentis Deemed Safe by Study

Avastin and Lucentis appear to be safe as far as the risk of cardiovascular problems are concerned. A study at Duke University School of Medicine analyzed the medical records of 146,942 patients treated for AMD in 2005-6. Patients receiving bevacizumab or ranibizumab did not have an increased risk of death, stroke or heart attack compared to patients receiving other treatments.